Meta-analysis of 22,710 human microbiome metagenomes defines an oral-to-gut microbial enrichment score and associations with host health and diseaseOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study analyzed a newly built resource called curatedMetagenomicData (cMD) 3, a uniformly processed collection of over 22,000 human microbiome samples with manually curated metadata. The researchers combined data across 94 studies and 42 countries to make large-scale meta-analysis possible, something that had been difficult due to a lack of standardization across public datasets. Using this resource, they searched for microbial species and functions associated with host traits and disease status. They also developed a new metric, the oral enrichment score (OES), based on the relative abundance in the gut of bacteria that are typically found in the oral cavity rather than the gut.
Who was studied?
The analysis drew on more than 22,000 human microbiome samples aggregated from 94 separate studies conducted across 42 countries. This is a public, pooled metagenomic dataset rather than a single original cohort recruited for this study. The abstract does not give specific demographic breakdowns beyond noting that sex, age, body mass index, and disease status were among the host variables examined across this large, internationally diverse sample collection.
What were the most important findings?
The meta-analysis identified hundreds of microbial species and thousands of microbial functions that were significantly associated with a person's sex, age, body mass index, and disease status. The team catalogued these associations as a reference resource for the field. Most notably, they found that a higher oral enrichment score (OES), meaning greater relative abundance of oral-type bacteria in the gut, was a consistent feature of individuals with disease. The overall patterns identified across the dataset were described as modest but widely shared across the many studies pooled together.
What are the greatest implications of this study?
The findings suggest that OES can serve as a simple, quantifiable signal of altered gut microbiome health, since oral bacteria showing up in the gut appears to track with disease status across many different conditions and populations. Because cMD 3 is described as reproducible and readily updatable, it offers an ongoing reference dataset that other researchers can use to validate microbiome-disease associations. This kind of large, standardized meta-analysis approach could help establish more generalizable, cross-study biomarkers of microbiome health rather than relying on findings from single, smaller cohorts.